A tailored course, built for your situation
Audit-Tested AI in Pharmaceutical R&D Operations for Senior Leaders
Implement AI systems in drug development with built-in audit readiness and regulatory confidence
The situation this course is for
As AI adoption accelerates in pharmaceutical research, many teams still operate in silos, developing powerful models that fail under inspection due to poor documentation, unvalidated inputs, or unclear ownership. This leads to rework, delayed timelines, and eroded trust from quality and compliance stakeholders.
Who this is for
Senior leaders in pharmaceutical R&D, quality assurance, regulatory operations, and technology innovation who are responsible for delivering AI-enabled solutions that meet GxP, 21 CFR Part 11, and internal audit standards
Who this is not for
This course is not for entry-level data scientists or those seeking introductory AI training. It assumes familiarity with AI/ML concepts and pharmaceutical development workflows.
What you walk away with
- Design AI systems with embedded compliance and audit readiness
- Navigate regulatory expectations for AI use in GxP environments
- Build cross-functional validation workflows that satisfy inspectors
- Document AI decision trails to meet data integrity standards
- Lead AI adoption with confidence across R&D, QA, and regulatory teams
The 12 modules (with all 144 chapters)
- Defining audit-tested AI
- Regulatory drivers shaping AI use
- Key differences from traditional software validation
- Role of ALCOA+ in AI systems
- Integration with quality management systems
- Risk-based approach to AI oversight
- Case study: AI in preclinical dose prediction
- Common pitfalls in early deployment
- Stakeholder alignment across functions
- Documentation expectations up front
- Establishing AI governance charter
- Building audit mindset into development
- Applying ALCOA+ to training datasets
- Data provenance tracking methods
- Version control for datasets
- Handling missing or anomalous data
- Audit trail requirements for data pipelines
- Role of metadata in reproducibility
- Validating external data sources
- Data access and ownership policies
- Automated data quality checks
- Documentation templates for data lineage
- Change management for data updates
- Case study: data drift in clinical trial AI
- Version control for model code
- Reproducible environments using containers
- Model configuration management
- Code review processes for compliance
- Integration with electronic lab notebooks
- Tracking hyperparameters and experiments
- Model card documentation
- Bias and fairness assessment workflows
- Defining model scope and limitations
- Audit expectations for training workflows
- Validation of development tools
- Case study: model reproducibility failure
- Risk assessment for AI applications
- Determining validation scope
- Designing test protocols
- Performance benchmarking
- Handling model uncertainty
- Validation of inference pipelines
- Ongoing monitoring requirements
- Change impact analysis
- Retraining validation workflows
- Documentation for inspectors
- Role of IQ/OQ/PQ in AI
- Case study: validating an AI-based formulation optimizer
- Defining AI system boundaries
- Change classification frameworks
- Impact assessment for updates
- Approval workflows for model changes
- Versioning strategy for models
- Rollback and recovery planning
- Audit trail for model updates
- Deprecation and retirement protocols
- Managing technical debt in AI
- Integration with CAPA systems
- Vendor change management
- Case study: unapproved model update
- Structure of AI documentation packages
- Model summary reports
- Data and algorithm transparency
- Handling proprietary algorithms
- Redaction strategies for IP
- Submission formats for agencies
- Preparing for inspector questions
- Common deficiencies in AI submissions
- Cross-border regulatory alignment
- Using templates for consistency
- Version control for submissions
- Case study: successful AI submission
- Defining roles in AI projects
- RACI for AI development
- Bridging language gaps between teams
- Joint risk assessment sessions
- Synchronizing timelines across functions
- Conflict resolution in AI projects
- Knowledge transfer between data scientists and QA
- Building shared KPIs
- Facilitating audit readiness reviews
- Creating feedback loops
- Governance committee operations
- Case study: interdisciplinary AI rollout
- Designing monitoring dashboards
- Tracking model drift
- Performance degradation alerts
- Feedback from end users
- Integration with quality event systems
- Automated retraining triggers
- Human-in-the-loop workflows
- Incident response for AI failures
- Audit trail for inference decisions
- Handling edge cases
- Periodic performance reviews
- Case study: undetected model drift
- Due diligence for AI vendors
- Assessing vendor compliance posture
- Contractual requirements for audit access
- Data security in third-party AI
- Right to audit clauses
- Oversight of SaaS-based AI
- Validation of vendor models
- Managing black-box systems
- Documentation expectations from vendors
- Exit strategies and data portability
- Ongoing vendor performance review
- Case study: vendor model failure
- Defining responsible AI in pharma
- Bias assessment frameworks
- Fairness in clinical data
- Transparency vs. IP protection
- Stakeholder engagement strategies
- Ethics review board integration
- Handling sensitive patient data
- Public trust considerations
- Global perspectives on AI ethics
- Documentation of ethical review
- Balancing innovation and caution
- Case study: ethical concerns in AI trial design
- Common inspector questions about AI
- Preparing documentation dossiers
- Conducting mock audits
- Training staff for interviews
- Response protocols for findings
- Handling requests for source code
- Demonstrating model validation
- Presenting AI change history
- Audit communication strategy
- Post-inspection follow-up
- Lessons from past inspections
- Case study: passing an AI-focused audit
- Assessing organizational readiness
- Building AI centers of excellence
- Standardizing governance frameworks
- Knowledge sharing across teams
- Training programs for different roles
- Metrics for AI maturity
- Budgeting for compliance overhead
- Integrating AI into portfolio planning
- Change management for AI culture
- Lessons from leading organizations
- Roadmap for continuous improvement
- Case study: enterprise-wide AI rollout
How this maps to your situation
- Deploying AI models in regulated environments
- Leading cross-functional teams through validation
- Responding to regulatory feedback on AI systems
- Scaling AI initiatives across R&D functions
Before vs. after
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 4-6 hours per module, designed for busy professionals to complete at their own pace over 12 weeks.
How this compares to the alternatives
Unlike generic AI courses or academic programs, this offering is specifically tailored to pharmaceutical R&D operations, with implementation-grade detail on audit requirements, regulatory alignment, and cross-functional workflows.
Frequently asked
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.